Multi-copper oxidases and human iron metabolism

Nutrients

Volumn 5, Issue 7, 2013, Pages 2289-2313

  Vashchenko, Ganna ^a   MacGillivray, Ross T A ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Ceruloplasmin; Ferroxidase; Hephaestin; Multi copper oxidase; Zyklopen

Indexed keywords

CERULOPLASMIN; FERRIC ION; FERROPORTIN; FERROUS ION; HEPHAESTIN; IRON; MULTICOPPER OXIDASE; OXIDOREDUCTASE; OXYGEN; TRANSFERRIN; UNCLASSIFIED DRUG; WATER; ZYKLOPEN;

BLOOD; DIETARY INTAKE; ENZYME ACTIVITY; ENZYME SUBSTRATE; FETUS; HUMAN; INTESTINE CELL; IRON METABOLISM; IRON TRANSPORT; MOTHER; OXIDATION; PLACENTA; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; TROPHOBLAST;

EID: 84879585295     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5072289     Document Type: Review

References (149)

1. Crichton, R.R.; Pierre, J.L. Old iron, young copper: From Mars to Venus. Biometals 2001, 14, 99-112.
2. Ponka, P. Cell biology of heme. Am. J. Med. Sci. 1999, 318, 241-256.
3. Danielson, P.B. The cytochrome P450 superfamily: Biochemistry, evolution and drug metabolism in humans. Curr. Drug Metab. 2002, 3, 561-597.
4. Lill, R.; Muhlenhoff, U. Iron-sulfur protein biogenesis in eukaryotes: Components and mechanisms. Annu. Rev. Cell Dev. Biol. 2006, 22, 457-486.
5. Eklund, H.; Uhlin, U.; Farnegardh, M.; Logan, D.T.; Nordlund, P. Structure and function of the radical enzyme ribonucleotide reductase. Prog. Biophys. Mol. Biol. 2001, 77, 177-268.
6. Wink, D.A.; Hines, H.B.; Cheng, R.Y.; Switzer, C.H.; Flores-Santana, W.; Vitek, M.P.; Ridnour, L.A.; Colton, C.A. Nitric oxide and redox mechanisms in the immune response. J. Leukoc. Biol. 2011, 89, 873-891.
7. Pierre, J.L.; Fontecave, M. Iron and activated oxygen species in biology: The basic chemistry. Biometals 1999, 12, 195-199.
8. Taketani, S. Aquisition, mobilization and utilization of cellular iron and heme: Endless findings and growing evidence of tight regulation. Tohoku J. Exp. Med. 2005, 205, 297-318.
9. Micronutrient Deficiencies. Available online: http://www.who.int/nutrition/topics/ida/en/ (accessed 1 March 2013).
10. Theil, E.C. Iron homeostasis and nutritional iron deficiency. J. Nutr. 2011, 141, 724S-728S.
11. Shayeghi, M.; Latunde-Dada, G.O.; Oakhill, J.S.; Laftah, A.H.; Takeuchi, K.; Halliday, N.; Khan, Y.; Warley, A.; McCann, F.E.; Hider, R.C. et al. Identification of an intestinal heme transporter. Cell 2005, 122, 789-801.
12. Rajagopal, A.; Rao, A.U.; Amigo, J.; Tian, M.; Upadhyay, S.K.; Hall, C.; Uhm, S.; Mathew, M.K.; Fleming, M.D.; Paw, B.H. et al. Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature 2008, 453, 1127-1131.
13. Latunde-Dada, G.O.; Takeuchi, K.; Simpson, R.J.; McKie, A.T. Haem carrier protein 1 (HCP1): Expression and functional studies in cultured cells. FEBS Lett. 2006, 580, 6865-6870.
14. Gunshin, H.; Mackenzie, B.; Berger, U.V.; Gunshin, Y.; Romero, M.F.; Boron, W.F.; Nussberger, S.; Gollan, J.L.; Hediger, M.A. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 1997, 388, 482-488.
15. Gunshin, H.; Fujiwara, Y.; Custodio, A.O.; Direnzo, C.; Robine, S.; Andrews, N.C. Slc11a2 is required for intestinal iron absorption and erythropoiesis but dispensable in placenta and liver. J. Clin. Investig. 2005, 115, 1258-1266.
16. McKie, A.T.; Barrow, D.; Latunde-Dada, G.O.; Rolfs, A.; Sager, G.; Mudaly, E.; Mudaly, M.; Richardson, C.; Barlow, D.; Bomford, A. et al. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 2001, 291, 1755-1759.
17. McKie, A.T. The role of Dcytb in iron metabolism: An update. Biochem. Soc. Trans. 2008, 36, 1239-1241.
18. Wyman, S.; Simpson, R.J.; McKie, A.T.; Sharp, P.A. Dcytb (Cybrd1) functions as both a ferric and a cupric reductase in vitro. FEBS Lett. 2008, 582, 1901-1906.
19. Scheers, N. Regulatory effects of Cu, Zn, and Ca on Fe absorption: The intricate play between nutrient transporters. Nutrients 2013, 5, 957-970.
20. Gunshin, H.; Starr, C.N.; Direnzo, C.; Fleming, M.D.; Jin, J.; Greer, E.L.; Sellers, V.M.; Galica, S.M.; Andrews, N.C. Cybrd1 (duodenal cytochrome b) is not necessary for dietary iron absorption in mice. Blood 2005, 106, 2879-2883.
21. Chasteen, N.D.; Harrison, P.M. Mineralization in ferritin: An efficient means of iron storage. J. Struct. Biol. 1999, 126, 182-194.
22. Miller, L.L.; Miller, S.C.; Torti, S.V.; Tsuji, Y.; Torti, F.M. Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc. Natl. Acad. Sci. USA 1991, 88, 4946-4950.
23. Leggett, B.A.; Fletcher, L.M.; Ramm, G.A.; Powell, L.W.; Halliday, J.W. Differential regulation of ferritin H and L subunit mRNA during inflammation and long-term iron overload. J. Gastroenterol. Hepatol. 1993, 8, 21-27.
24. Shaw, G.C.; Cope, J.J.; Li, L.; Corson, K.; Hersey, C.; Ackermann, G.E.; Gwynn, B.; Lambert, A.J.; Wingert, R.A.; Traver, D. et al. Mitoferrin is essential for erythroid iron assimilation. Nature 2006, 440, 96-100.
25. Li, F.Y.; Nikali, K.; Gregan, J.; Leibiger, I.; Leibiger, B.; Schweyen, R.; Larsson, C.; Suomalainen, A. Characterization of a novel human putative mitochondrial transporter homologous to the yeast mitochondrial RNA splicing proteins 3 and 4. FEBS Lett. 2001, 494, 79-84.
26. Bencze, K.Z.; Kondapalli, K.C.; Cook, J.D.; McMahon, S.; Millan-Pacheco, C.; Pastor, N.; Stemmler, T.L. The structure and function of frataxin. Crit. Rev. Biochem. Mol. Biol. 2006, 41, 269-291.
27. Levi, S.; Arosio, P. Mitochondrial ferritin. Int. J. Biochem. Cell Biol. 2004, 36, 1887-1889.
28. Donovan, A.; Lima, C.A.; Pinkus, J.L.; Pinkus, G.S.; Zon, L.I.; Robine, S.; Andrews, N.C. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 2005, 1, 191-200.
29. Jeong, S.Y.; David, S. Glycosylphosphatidylinositol-anchored ceruloplasmin is required for iron efflux from cells in the central nervous system. J. Biol. Chem. 2003, 278, 27144-27148.
30. De Domenico, I.; Ward, D.M.; di Patti, M.C.; Jeong, S.Y.; David, S.; Musci, G.; Kaplan, J. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin. EMBO J. 2007, 26, 2823-2831.
31. Kono, S.; Yoshida, K.; Tomosugi, N.; Terada, T.; Hamaya, Y.; Kanaoka, S.; Miyajima, H. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin. Biochim. Biophys. Acta 2010, 1802, 968-975.
32. Han, O.; Kim, E.Y. Colocalization of ferroportin-1 with hephaestin on the basolateral membrane of human intestinal absorptive cells. J. Cell. Biochem. 2007, 101, 1000-1010.
33. Yeh, K.Y.; Yeh, M.; Mims, L.; Glass, J. Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium. Am. J. Physiol. Gastrointest. Liver Physiol. 2009, 296, G55-G65.
34. Aisen, P.; Leibman, A.; Zweier, J. Stoichiometric and site characteristics of the binding of iron to human transferrin. J. Biol. Chem. 1978, 253, 1930-1937.
35. Ha-Duong, N.T.; Eid, C.; Hemadi, M.; El Hage Chahine, J.M. In vitro interaction between ceruloplasmin and human serum transferrin. Biochemistry 2010, 49, 10261-10263.
36. Zakharova, E.T.; Shavlovski, M.M.; Bass, M.G.; Gridasova, A.A.; Pulina, M.O.; de Filippis, V.; Beltramini, M.; di Muro, P.; Salvato, B.; Fontana, A.; et al. Interaction of lactoferrin with ceruloplasmin. Arch. Biochem. Biophys. 2000, 374, 222-228.
37. Hudson, D.M.; Krisinger, M.J.; Griffiths, T.A.; MacGillivray, R.T. Neither human hephaestin nor ceruloplasmin forms a stable complex with transferrin. J. Cell. Biochem. 2008, 103, 1849-1855.
38. Dautry-Varsat, A.; Ciechanover, A.; Lodish, H.F. pH and the recycling of transferrin during receptor-mediated endocytosis. Proc. Natl. Acad. Sci. USA 1983, 80, 2258-2262.
39. Kawabata, H.; Germain, R.S.; Vuong, P.T.; Nakamaki, T.; Said, J.W.; Koeffler, H.P. Transferrin receptor 2-alpha supports cell growth both in iron-chelated cultured cells and in vivo. J. Biol. Chem. 2000, 275, 16618-16625.
40. Trinder, D.; Baker, E. Transferrin receptor 2: A new molecule in iron metabolism. Int. J. Biochem. Cell Biol. 2003, 35, 292-296.
41. Ohgami, R.S.; Campagna, D.R.; Greer, E.L.; Antiochos, B.; McDonald, A.; Chen, J.; Sharp, J.J.; Fujiwara, Y.; Barker, J.E.; Fleming, M.D. Identification of a ferrireductase required for efficient transferrin-dependent iron uptake in erythroid cells. Nat. Genet. 2005, 37, 1264-1269.
42. Knutson, M.D. Steap proteins: Implications for iron and copper metabolism. Nutr. Rev. 2007, 65, 335-340.
43. Liuzzi, J.P.; Aydemir, F.; Nam, H.; Knutson, M.D.; Cousins, R.J. Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells. Proc. Natl. Acad. Sci. USA 2006, 103, 13612-13617.
44. Christensen, E.I.; Birn, H. Megalin and cubilin: Multifunctional endocytic receptors. Nat. Rev. Mol. Cell Biol. 2002, 3, 256-266.
45. Hvidberg, V.; Jacobsen, C.; Strong, R.K.; Cowland, J.B.; Moestrup, S.K.; Borregaard, N. The endocytic receptor megalin binds the iron transporting neutrophil-gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett. 2005, 579, 773-777.
46. Smith, K.D. Iron metabolism at the host pathogen interface: Lipocalin 2 and the pathogen-associated iroA gene cluster. Int. J. Biochem. Cell Biol. 2007, 39, 1776-1780.
47. Devireddy, L.R.; Gazin, C.; Zhu, X.; Green, M.R. A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 2005, 123, 1293-1305.
48. Knutson, M.; Wessling-Resnick, M. Iron metabolism in the reticuloendothelial system. Crit. Rev. Biochem. Mol. Biol. 2003, 38, 61-88.
49. Nielsen, M.J.; Moller, H.J.; Moestrup, S.K. Hemoglobin and heme scavenger receptors. Antioxid. Redox. Signal. 2010, 12, 261-273.
50. Troadec, M.B.; Ward, D.M.; Kaplan, J. A Tf-independent iron transport system required for organogenesis. Dev. Cell 2009, 16, 3-4.
51. Chen, T.T.; Li, L.; Chung, D.H.; Allen, C.D.; Torti, S.V.; Torti, F.M.; Cyster, J.G.; Chen, C.Y.; Brodsky, F.M.; Niemi, E.C. et al. TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis. J. Exp. Med. 2005, 202, 955-965.
52. Li, L.; Fang, C.J.; Ryan, J.C.; Niemi, E.C.; Lebron, J.A.; Bjorkman, P.J.; Arase, H.; Torti, F.M.; Torti, S.V.; Nakamura, M.C. et al. Binding and uptake of H-ferritin are mediated by human transferrin receptor-1. Proc. Natl. Acad. Sci. USA 2010, 107, 3505-3510.
53. Mukhopadhyay, C.K.; Attieh, Z.K.; Fox, P.L. Role of ceruloplasmin in cellular iron uptake. Science 1998, 279, 714-717.
54. Hentze, M.W.; Muckenthaler, M.U.; Andrews, N.C. Balancing acts: Molecular control of mammalian iron metabolism. Cell 2004, 117, 285-297.
55. Eisenstein, R.S.; Ross, K.L. Novel roles for iron regulatory proteins in the adaptive response to iron deficiency. J. Nutr. 2003, 133, 1510S-1516S.
56. McKie, A.T.; Marciani, P.; Rolfs, A.; Brennan, K.; Wehr, K.; Barrow, D.; Miret, S.; Bomford, A.; Peters, T.J.; Farzaneh, F. et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 2000, 5, 299-309.
57. Zhang, D.L.; Hughes, R.M.; Ollivierre-Wilson, H.; Ghosh, M.C.; Rouault, T.A. A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression. Cell Metab. 2009, 9, 461-473.
58. Lee, P.L.; Gelbart, T.; West, C.; Halloran, C.; Beutler, E. The human Nramp2 gene: Characterization of the gene structure, alternative splicing, promoter region and polymorphisms. Blood Cells Mol. Dis. 1998, 24, 199-215.
59. Meyron-Holtz, E.G.; Ghosh, M.C.; Iwai, K.; LaVaute, T.; Brazzolotto, X.; Berger, U.V.; Land, W.; Ollivierre-Wilson, H.; Grinberg, A.; Love, P. et al. Genetic ablations of iron regulatory proteins 1 and 2 reveal why iron regulatory protein 2 dominates iron homeostasis. EMBO J. 2004, 23, 386-395.
60. Smith, S.R.; Ghosh, M.C.; Ollivierre-Wilson, H.; Tong, W.H.; Rouault, T.A. Complete loss of iron regulatory proteins 1 and 2 prevents viability of murine zygotes beyond the blastocyst stage of embryonic development. Blood Cells Mol. Dis. 2006, 36, 283-287.
61. Fleming, R.E.; Sly, W.S. Hepcidin: A putative iron-regulatory hormone relevant to hereditary hemochromatosis and the anemia of chronic disease. Proc. Natl. Acad. Sci. USA 2001, 98, 8160-8162.
62. Nemeth, E.; Tuttle, M.S.; Powelson, J.; Vaughn, M.B.; Donovan, A.; Ward, D.M.; Ganz, T.; Kaplan, J. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 2004, 306, 2090-2093.
63. Bardou-Jacquet, E.; Island, M.L.; Jouanolle, A.M.; Detivaud, L.; Fatih, N.; Ropert, M.; Brissot, E.; Mosser, A.; Maisonneuve, H.; Brissot, P. et al. A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload. Blood Cells Mol. Dis. 2011, 47, 243-248.
64. Beaumont, C.; Delaunay, J.; Hetet, G.; Grandchamp, B.; de Montalembert, M.; Tchernia, G. Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 2006, 107, 4168-4170.
65. Blanco, E.; Kannengiesser, C.; Grandchamp, B.; Tasso, M.; Beaumont, C. Not all DMT1 mutations lead to iron overload. Blood Cells Mol. Dis. 2009, 43, 199-201.
66. Kato, J.; Fujikawa, K.; Kanda, M.; Fukuda, N.; Sasaki, K.; Takayama, T.; Kobune, M.; Takada, K.; Takimoto, R.; Hamada, H. et al. A mutation, in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am. J. Hum. Genet. 2001, 69, 191-197.
67. Curtis, A.R.; Fey, C.; Morris, C.M.; Bindoff, L.A.; Ince, P.G.; Chinnery, P.F.; Coulthard, A.; Jackson, M.J.; Jackson, A.P.; McHale, D.P. et al. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet. 2001, 28, 350-354.
68. Levi, S.; Cozzi, A.; Arosio, P. Neuroferritinopathy: A neurodegenerative disorder associated with L-ferritin mutation. Best Pract. Res. Clin. Haematol. 2005, 18, 265-276.
69. Cazzola, M.; Bergamaschi, G.; Tonon, L.; Arbustini, E.; Grasso, M.; Vercesi, E.; Barosi, G.; Bianchi, P.E.; Cairo, G.; Arosio, P. Hereditary hyperferritinemia-cataract syndrome: Relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA. Blood 1997, 90, 814-821.
70. Koeppen, A.H. Friedreich's ataxia: Pathology, pathogenesis, and molecular genetics. J. Neurol. Sci. 2011, 303, 1-12.
71. De Domenico, I.; Ward, D.M.; Nemeth, E.; Vaughn, M.B.; Musci, G.; Ganz, T.; Kaplan, J. The molecular basis of ferroportin-linked hemochromatosis. Proc. Natl. Acad. Sci. USA 2005, 102, 8955-8960.
72. Xu, X.; Pin, S.; Gathinji, M.; Fuchs, R.; Harris, Z.L. Aceruloplasminemia: An inherited neurodegenerative disease with impairment of iron homeostasis. Ann. N. Y. Acad. Sci. 2004, 1012, 299-305.
73. Hamill, R.L.; Woods, J.C.; Cook, B.A. Congenital atransferrinemia. A case report and review of the literature. Am. J. Clin. Pathol. 1991, 96, 215-218.
74. Shamsian, B.S.; Rezaei, N.; Arzanian, M.T.; Alavi, S.; Khojasteh, O.; Eghbali, A. Severe hypochromic microcytic anemia in a patient with congenital atransferrinemia. Pediatr. Hematol. Oncol. 2009, 26, 356-362.
75. Chen, J.; Enns, C.A. Hereditary hemochromatosis and transferrin receptor 2. Biochim. Biophys. Acta 2011, 1820, 256-263.
76. Rochette, J.; le Gac, G.; Lassoued, K.; Ferec, C.; Robson, K.J. Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum. Genet. 2010, 128, 233-248.
77. Goldberg, Y.P. Juvenile Hereditary Hemochromatosis. In GeneReviews™ [Internet]; Pagon, R.A., Bird, T.D., Dolan, C.R., Stephens, K., Adam, M.P., Eds.; University of Washington: Seattle, WA, USA, 2011.
78. Sakurai, T.; Kataoka, K. Basic and applied features of multicopper oxidases, CueO, bilirubin oxidase, and laccase. Chem. Rec. 2007, 7, 220-229.
79. Kosman, D.J. Multicopper oxidases: A workshop on copper coordination chemistry, electron transfer, and metallophysiology. J. Biol. Inorg. Chem. 2010, 15, 15-28.
80. Nakamura, K.; Kawabata, T.; Yura, K.; Go, N. Novel types of two-domain multi-copper oxidases: Possible missing links in the evolution. FEBS Lett. 2003, 553, 239-244.
81. Skalova, T.; Dohnalek, J.; Ostergaard, L.H.; Ostergaard, P.R.; Kolenko, P.; Duskova, J.; Stepankova, A.; Hasek, J. The structure of the small laccase from Streptomyces coelicolor reveals a link between laccases and nitrite reductases. J. Mol. Biol. 2009, 385, 1165-1178.
82. Nakamura, K.; Go, N. Function and molecular evolution of multicopper blue proteins. Cell. Mol. Life Sci. 2005, 62, 2050-2066.
83. Giardina, P.; Faraco, V.; Pezzella, C.; Piscitelli, A.; Vanhulle, S.; Sannia, G. Laccases: A never-ending story. Cell. Mol. Life Sci. 2009, 67, 369-385.
84. Hirose, J.; Sakurai, T.; Imamura, K.; Watanabe, H.; Iwamoto, H.; Hiromi, K.; Itoh, H.; Shin, T.; Murao, S. Characterization of ascorbate oxidase from Acremonium sp. HI-25. J. Biochem. 1994, 115, 811-813.
85. Terzulli, A.; Kosman, D.J. Analysis of the high-affinity iron uptake system at the Chlamydomonas reinhardtii plasma membrane. Eukaryot. Cell 2010, 9, 815-826.
86. Roberts, S.A.; Weichsel, A.; Grass, G.; Thakali, K.; Hazzard, J.T.; Tollin, G.; Rensing, C.; Montfort, W.R. Crystal structure and electron transfer kinetics of CueO, a multicopper oxidase required for copper homeostasis in Escherichia coli. Proc. Natl. Acad. Sci. USA 2002, 99, 2766-2771.
87. Dick, G.J.; Torpey, J.W.; Beveridge, T.J.; Tebo, B.M. Direct identification of a bacterial manganese(II) oxidase, the multicopper oxidase MnxG, from spores of several different marine Bacillus species. Appl. Environ. Microbiol. 2008, 74, 1527-1534.
88. Palmer, A.E.; Szilagyi, R.K.; Cherry, J.R.; Jones, A.; Xu, F.; Solomon, E.I. Spectroscopic characterization of the Leu513His variant of fungal laccase: Effect of increased axial ligand interaction on the geometric and electronic structure of the type 1 Cu site. Inorg. Chem. 2003, 42, 4006-4017.
89. Xu, F.; Palmer, A.E.; Yaver, D.S.; Berka, R.M.; Gambetta, G.A.; Brown, S.H.; Solomon, E.I. Targeted mutations in a Trametes villosa laccase. Axial perturbations of the T1 copper. J. Biol. Chem. 1999, 274, 12372-12375.
90. Solomon, E.I.; Szilagyi, R.K.; DeBeer George, S.; Basumallick, L. Electronic structures of metal sites in proteins and models: Contributions to function in blue copper proteins. Chem. Rev. 2004, 104, 419-458.
91. Quintanar, L.; Stoj, C.; Taylor, A.B.; Hart, P.J.; Kosman, D.J.; Solomon, E.I. Shall we dance? How a multicopper oxidase chooses its electron transfer partner. Acc. Chem. Res. 2007, 40, 445-452.
92. Solomon, E.I. Spectroscopic methods in bioinorganic chemistry: Blue to green to red copper sites. Inorg. Chem. 2006, 45, 8012-8025.
93. Sakurai, T.; Kataoka, K. Structure and function of type I copper in multicopper oxidases. Cell. Mol. Life Sci. 2007, 64, 2642-2656.
94. Quintanar, L.; Stoj, C.; Wang, T.P.; Kosman, D.J.; Solomon, E.I. Role of aspartate 94 in the decay of the peroxide intermediate in the multicopper oxidase Fet3p. Biochemistry 2005, 44, 6081-6091.
95. Yoon, J.; Solomon, E.I. Electronic structure of the peroxy intermediate and its correlation to the native intermediate in the multicopper oxidases: Insights into the reductive cleavage of the O-O bond. J. Am. Chem. Soc. 2007, 129, 13127-13136.
96. Yoon, J.; Liboiron, B.D.; Sarangi, R.; Hodgson, K.O.; Hedman, B.; Solomon, E.I. The two oxidized forms of the trinuclear Cu cluster in the multicopper oxidases and mechanism for the decay of the native intermediate. Proc. Natl. Acad. Sci. USA 2007, 104, 13609-13614.
97. Solomon, E.I.; Augustine, A.J.; Yoon, J. O2 reduction to H2O by the multicopper oxidases. Dalton Trans. 2008, 3921-3932.
98. Holmberg, C.G.; Laurell, C.B. Investigations in serum copper. II. Isolation of copper containing protein, and a description of some of its properties. Acta Chem. Scand. 1948, 2, 550-556.
99. Osaki, S.; Johnson, D.A.; Frieden, E. The possible significance of the ferrous oxidase activity of ceruloplasmin in normal human serum. J. Biol. Chem. 1966, 241, 2746-2751.
100. Healy, J.; Tipton, K. Ceruloplasmin and what it might do. J. Neural Transm. 2007, 114, 777-781.
101. Patel, B.N.; David, S. A novel glycosylphosphatidylinositol-anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 1997, 272, 20185-20190.
102. Hahn, P.; Qian, Y.; Dentchev, T.; Chen, L.; Beard, J.; Harris, Z.L.; Dunaief, J.L. Disruption of ceruloplasmin and hephaestin in mice causes retinal iron overload and retinal degeneration with features of age-related macular degeneration. Proc. Natl. Acad. Sci. USA 2004, 101, 13850-13855.
103. Fortna, R.R.; Watson, H.A.; Nyquist, S.E. Glycosyl phosphatidylinositol-anchored ceruloplasmin is expressed by rat Sertoli cells and is concentrated in detergent-insoluble membrane fractions. Biol. Reprod. 1999, 61, 1042-1049.
104. Vachette, P.; Dainese, E.; Vasyliev, V.B.; di Muro, P.; Beltramini, M.; Svergun, D.I.; de Filippis, V.; Salvato, B. A key structural role for active site type 3 copper ions in human ceruloplasmin. J. Biol. Chem. 2002, 277, 40823-40831.
105. Lindley, P.F.; Card, G.; Zaitseva, I.; Zaitsev, V.; Reinhammar, B.; Selin-Lindgren, E.; Yoshida, K. An X-ray structural study of human ceruloplasmin in relation to ferroxidase activity. J. Biol. Inorg. Chem. 1997, 2, 454-463.
106. Quintanar, L.; Gebhard, M.; Wang, T.P.; Kosman, D.J.; Solomon, E.I. Ferrous binding to the multicopper oxidases Saccharomyces cerevisiae Fet3p and human ceruloplasmin: Contributions to ferroxidase activity. J. Am. Chem. Soc. 2004, 126, 6579-6589.
107. Machonkin, T.E.; Zhang, H.H.; Hedman, B.; Hodgson, K.O.; Solomon, E.I. Spectroscopic and magnetic studies of human ceruloplasmin: Identification of a redox-inactive reduced type 1 copper site. Biochemistry 1998, 37, 9570-9578.
108. Brown, M.A.; Stenberg, L.M.; Mauk, A.G. Identification of catalytically important amino acids in human ceruloplasmin by site-directed mutagenesis. FEBS Lett. 2002, 520, 8-12.
109. Inoue, K.; Akaike, T.; Miyamoto, Y.; Okamoto, T.; Sawa, T.; Otagiri, M.; Suzuki, S.; Yoshimura, T.; Maeda, H. Nitrosothiol formation catalyzed by ceruloplasmin. Implication for cytoprotective mechanism in vivo. J. Biol. Chem. 1999, 274, 27069-27075.
110. Cha, M.K.; Kim, I.H. Ceruloplasmin has a distinct active site for the catalyzing glutathione-dependent reduction of alkyl hydroperoxide. Biochemistry 1999, 38, 12104-12110.
111. Stoj, C.; Kosman, D.J. Cuprous oxidase activity of yeast Fet3p and human ceruloplasmin: Implication for function. FEBS Lett. 2003, 554, 422-426.
112. Mukhopadhyay, C.K.; Mazumder, B.; Lindley, P.F.; Fox, P.L. Identification of the prooxidant site of human ceruloplasmin: A model for oxidative damage by copper bound to protein surfaces. Proc. Natl. Acad. Sci. USA 1997, 94, 11546-11551.
113. Young, S.N.; Curzon, G. A method for obtaining linear reciprocal plots with caeruloplasmin and its application in a study of the kinetic parameters of caeruloplasmin substrates. Biochem. J. 1972, 129, 273-283.
114. McDermott, J.A.; Huber, C.T.; Osaki, S.; Frieden, E. Role of iron in the oxidase activity of ceruloplasmin. Biochim. Biophys. Acta. 1968, 151, 541-557.
115. Zaitsev, V.N.; Zaitseva, I.; Papiz, M.; Lindley, P.F. An X-ray crystallographic study of the binding sites of the azide inhibitor and organic substrates to ceruloplasmin, a multi-copper oxidase in the plasma. J. Biol. Inorg. Chem. 1999, 4, 579-587.
116. Harris, Z.L.; Takahashi, Y.; Miyajima, H.; Serizawa, M.; MacGillivray, R.T.; Gitlin, J.D. Aceruloplasminemia: Molecular characterization of this disorder of iron metabolism. Proc. Natl. Acad. Sci. USA 1995, 92, 2539-2543.
117. Yazaki, M.; Yoshida, K.; Nakamura, A.; Furihata, K.; Yonekawa, M.; Okabe, T.; Yamashita, N.; Ohta, M.; Ikeda, S. A novel splicing mutation in the ceruloplasmin gene responsible for hereditary ceruloplasmin deficiency with hemosiderosis. J. Neurol. Sci. 1998, 156, 30-34.
118. Kono, S.; Suzuki, H.; Oda, T.; Shirakawa, K.; Takahashi, Y.; Kitagawa, M.; Miyajima, H. Cys-881 is essential for the trafficking and secretion of truncated mutant ceruloplasmin in aceruloplasminemia. J. Hepatol. 2007, 47, 844-850.
119. Hellman, N.E.; Kono, S.; Miyajima, H.; Gitlin, J.D. Biochemical analysis of a missense mutation in aceruloplasminemia. J. Biol. Chem. 2002, 277, 1375-1380.
120. Kono, S.; Suzuki, H.; Takahashi, K.; Takahashi, Y.; Shirakawa, K.; Murakawa, Y.; Yamaguchi, S.; Miyajima, H. Hepatic iron overload associated with a decreased serum ceruloplasmin level in a novel clinical type of aceruloplasminemia. Gastroenterology 2006, 131, 240-245.
121. Patel, B.N.; Dunn, R.J.; Jeong, S.Y.; Zhu, Q.; Julien, J.P.; David, S. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 2002, 22, 6578-6586.
122. Vulpe, C.D.; Kuo, Y.M.; Murphy, T.L.; Cowley, L.; Askwith, C.; Libina, N.; Gitschier, J.; Anderson, G.J. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 1999, 21, 195-199.
123. Edwards, J.A.; Bannerman, R.M. Hereditary defect of intestinal iron transport in mice with sex-linked anemia. J. Clin. Investig. 1970, 49, 1869-1871.
124. Syed, B.A.; Beaumont, N.J.; Patel, A.; Naylor, C.E.; Bayele, H.K.; Joannou, C.L.; Rowe, P.S.; Evans, R.W.; Srai, S.K. Analysis of the human hephaestin gene and protein: Comparative modelling of the N-terminus ecto-domain based upon ceruloplasmin. Protein Eng. 2002, 15, 205-214.
125. Frazer, D.M.; Vulpe, C.D.; McKie, A.T.; Wilkins, S.J.; Trinder, D.; Cleghorn, G.J.; Anderson, G.J. Cloning and gastrointestinal expression of rat hephaestin: Relationship to other iron transport proteins. Am. J. Physiol. Gastrointest. Liver Physiol. 2001, 281, G931-G939.
126. Hudson, D.M.; Curtis, S.B.; Smith, V.C.; Griffiths, T.A.; Wong, A.Y.; Scudamore, C.H.; Buchan, A.M.; MacGillivray, R.T. Human hephaestin expression is not limited to enterocytes of the gastrointestinal tract but is also found in the antrum, the enteric nervous system, and pancreatic β-cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G425-G432.
127. Qian, Z.M.; Chang, Y.Z.; Leung, G.; Du, J.R.; Zhu, L.; Wang, Q.; Niu, L.; Xu, Y.J.; Yang, L.; Ho, K.P. et al. Expression of ferroportin1, hephaestin and ceruloplasmin in rat heart. Biochim. Biophys. Acta 2007, 1772, 527-532.
128. Qian, Z.M.; Chang, Y.Z.; Zhu, L.; Yang, L.; Du, J.R.; Ho, K.P.; Wang, Q.; Li, L.Z.; Wang, C.Y.; Ge, X. et al. Development and iron-dependent expression of hephaestin in different brain regions of rats. J. Cell. Biochem. 2007, 102, 1225-1233.
129. Kingston, P.J.; Bannerman, C.E.; Bannerman, R.M. Iron deficiency anaemia in newborn sla mice: A genetic defect of placental iron transport. Br. J. Haematol. 1978, 40, 265-276.
130. Vashchenko, G.; Bleackley, M.R.; Griffiths, T.A.; MacGillivray, R.T. Oxidation of organic and biogenic amines by recombinant human hephaestin expressed in Pichia pastoris. Arch. Biochem. Biophys. 2011, 514, 50-56.
131. Vashchenko, G.; Macgillivray, R.T. Functional role of the putative iron ligands in the ferroxidase activity of recombinant human hephaestin. J. Biol. Inorg. Chem. 2012, 17, 1187-1195.
132. Chen, H.; Attieh, Z.K.; Syed, B.A.; Kuo, Y.M.; Stevens, V.; Fuqua, B.K.; Andersen, H.S.; Naylor, C.E.; Evans, R.W.; Gambling, L. et al. Identification of zyklopen, a new member of the vertebrate multicopper ferroxidase family, and characterization in rodents and human cells. J. Nutr. 2010, 140, 1728-1735.
133. Danzeisen, R.; Ponnambalam, S.; Lea, R.G.; Page, K.; Gambling, L.; McArdle, H.J. The effect of ceruloplasmin on iron release from placental (BeWo) cells; evidence for an endogenous Cu oxidase. Placenta 2000, 21, 805-812.
134. Danzeisen, R.; Fosset, C.; Chariana, Z.; Page, K.; David, S.; McArdle, H.J. Placental ceruloplasmin homolog is regulated by iron and copper and is implicated in iron metabolism. Am. J. Physiol. Cell Physiol. 2002, 282, C472-C478.
135. Cui, R.; Duan, X.L.; Anderson, G.J.; Qiao, Y.T.; Yu, P.; Qian, Z.M.; Yoshida, K.; Takeda, S.; Guo, P.; Yang, Z.L. et al. Age-dependent expression of hephaestin in the brain of ceruloplasmin-deficient mice. J. Trace Elem. Med. Biol. 2009, 23, 290-299.
136. Harris, Z.L.; Durley, A.P.; Man, T.K.; Gitlin, J.D. Targeted gene disruption reveals an essential role for ceruloplasmin in cellular iron efflux. Proc. Natl. Acad. Sci. USA 1999, 96, 10812-10817.
137. Bannerman, R.M.; Cooper, R.G. Sex-linked anemia: A hypochromic anemia of mice. Science 1966, 151, 581-582.
138. Li, Y.Q.; Bai, B.; Cao, X.X.; Yan, H.; Zhuang, G.H. Ferroportin 1 and hephaestin expression in BeWo cell line with different iron treatment. Cell Biochem. Funct. 2012, 30, 249-255.
139. Cherukuri, S.; Potla, R.; Sarkar, J.; Nurko, S.; Harris, Z.L.; Fox, P.L. Unexpected role of ceruloplasmin in intestinal iron absorption. Cell Metab. 2005, 2, 309-319.
140. Mukhopadhyay, C.K.; Mazumder, B.; Fox, P.L. Role of hypoxia-inducible factor-1 in transcriptional activation of ceruloplasmin by iron deficiency. J. Biol. Chem. 2000, 275, 21048-21054.
141. Tapryal, N.; Mukhopadhyay, C.; Das, D.; Fox, P.L.; Mukhopadhyay, C.K. Reactive oxygen species regulate ceruloplasmin by a novel mRNA decay mechanism involving its 3′-untranslated region: Implications in neurodegenerative diseases. J. Biol. Chem. 2009, 284, 1873-1883.
142. Sampath, P.; Mazumder, B.; Seshadri, V.; Fox, P.L. Transcript-selective translational silencing by gamma interferon is directed by a novel structural element in the ceruloplasmin mRNA 3′ untranslated region. Mol. Cell. Biol. 2003, 23, 1509-1519.
143. Persichini, T.; Maio, N.; di Patti, M.C.; Rizzo, G.; Toscano, S.; Colasanti, M.; Musci, G. Interleukin-1beta induces ceruloplasmin and ferroportin-1 gene expression via MAP kinases and C/EBPbeta, AP-1, and NF-kappaB activation. Neurosci. Lett. 2010, 484, 133-138.
144. Chen, H.; Su, T.; Attieh, Z.K.; Fox, T.C.; McKie, A.T.; Anderson, G.J.; Vulpe, C.D. Systemic regulation of Hephaestin and Ireg1 revealed in studies of genetic and nutritional iron deficiency. Blood 2003, 102, 1893-1899.
145. Lee, S.M.; Attieh, Z.K.; Son, H.S.; Chen, H.; Bacouri-Haidar, M.; Vulpe, C.D. Iron repletion relocalizes hephaestin to a proximal basolateral compartment in polarized MDCK and Caco2 cells. Biochem. Biophys. Res. Commun. 2012, 421, 449-455.
146. Hinoi, T.; Gesina, G.; Akyol, A.; Kuick, R.; Hanash, S.; Giordano, T.J.; Gruber, S.B.; Fearon, E.R. CDX2-regulated expression of iron transport protein hephaestin in intestinal and colonic epithelium. Gastroenterology 2005, 128, 946-961.
147. Nittis, T.; Gitlin, J.D. Role of copper in the proteosome-mediated degradation of the multicopper oxidase hephaestin. J. Biol. Chem. 2004, 279, 25696-25702.
148. Chen, H.; Huang, G.; Su, T.; Gao, H.; Attieh, Z.K.; McKie, A.T.; Anderson, G.J.; Vulpe, C.D. Decreased hephaestin activity in the intestine of copper-deficient mice causes systemic iron deficiency. J. Nutr. 2006, 136, 1236-1241.
149. Gitlin, J.D.; Schroeder, J.J.; Lee-Ambrose, L.M.; Cousins, R.J. Mechanisms of caeruloplasmin biosynthesis in normal and copper-deficient rats. Biochem. J. 1992, 282, 835-839.